Recent Analyst Forecasts and Stock Ratings
Enliven Therapeutics, Inc. FAQ's
Enliven Therapeutics, Inc. has been rated by research analysts at Robert W. Baird, Mizuho Securities in the past 90 days.
Enliven Therapeutics, Inc. has been rated by research analysts at Robert W. Baird, Mizuho Securities in the past 90 days.